| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |